Last reviewed · How we verify

Licensed quadrivalent HPV vaccine, Gardasil

Murdoch Childrens Research Institute · Phase 3 active Small molecule

Licensed quadrivalent HPV vaccine, Gardasil is a Prophylactic vaccine Small molecule drug developed by Murdoch Childrens Research Institute. It is currently in Phase 3 development for Prevention of cervical cancer caused by HPV types 16 and 18, Prevention of genital warts caused by HPV types 6 and 11, Prevention of anal cancer and other HPV-related cancers.

Gardasil is a quadrivalent vaccine that stimulates the immune system to produce antibodies against four types of human papillomavirus (HPV types 6, 11, 16, and 18).

Gardasil is a quadrivalent vaccine that stimulates the immune system to produce antibodies against four types of human papillomavirus (HPV types 6, 11, 16, and 18). Used for Prevention of cervical cancer caused by HPV types 16 and 18, Prevention of genital warts caused by HPV types 6 and 11, Prevention of anal cancer and other HPV-related cancers.

At a glance

Generic nameLicensed quadrivalent HPV vaccine, Gardasil
SponsorMurdoch Childrens Research Institute
Drug classProphylactic vaccine
TargetHuman papillomavirus (HPV) types 6, 11, 16, 18
ModalitySmall molecule
Therapeutic areaOncology / Immunology
PhasePhase 3

Mechanism of action

The vaccine contains virus-like particles (VLPs) derived from the major capsid protein of HPV types 6, 11, 16, and 18. When administered, these VLPs trigger a humoral immune response that generates neutralizing antibodies against these HPV types, preventing infection and subsequent development of HPV-related diseases. This prophylactic approach prevents cervical cancer, genital warts, and other HPV-associated malignancies before infection occurs.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Licensed quadrivalent HPV vaccine, Gardasil

What is Licensed quadrivalent HPV vaccine, Gardasil?

Licensed quadrivalent HPV vaccine, Gardasil is a Prophylactic vaccine drug developed by Murdoch Childrens Research Institute, indicated for Prevention of cervical cancer caused by HPV types 16 and 18, Prevention of genital warts caused by HPV types 6 and 11, Prevention of anal cancer and other HPV-related cancers.

How does Licensed quadrivalent HPV vaccine, Gardasil work?

Gardasil is a quadrivalent vaccine that stimulates the immune system to produce antibodies against four types of human papillomavirus (HPV types 6, 11, 16, and 18).

What is Licensed quadrivalent HPV vaccine, Gardasil used for?

Licensed quadrivalent HPV vaccine, Gardasil is indicated for Prevention of cervical cancer caused by HPV types 16 and 18, Prevention of genital warts caused by HPV types 6 and 11, Prevention of anal cancer and other HPV-related cancers.

Who makes Licensed quadrivalent HPV vaccine, Gardasil?

Licensed quadrivalent HPV vaccine, Gardasil is developed by Murdoch Childrens Research Institute (see full Murdoch Childrens Research Institute pipeline at /company/murdoch-childrens-research-institute).

What drug class is Licensed quadrivalent HPV vaccine, Gardasil in?

Licensed quadrivalent HPV vaccine, Gardasil belongs to the Prophylactic vaccine class. See all Prophylactic vaccine drugs at /class/prophylactic-vaccine.

What development phase is Licensed quadrivalent HPV vaccine, Gardasil in?

Licensed quadrivalent HPV vaccine, Gardasil is in Phase 3.

What are the side effects of Licensed quadrivalent HPV vaccine, Gardasil?

Common side effects of Licensed quadrivalent HPV vaccine, Gardasil include Injection site pain, Injection site swelling, Injection site erythema, Headache, Fever, Nausea.

What does Licensed quadrivalent HPV vaccine, Gardasil target?

Licensed quadrivalent HPV vaccine, Gardasil targets Human papillomavirus (HPV) types 6, 11, 16, 18 and is a Prophylactic vaccine.

Related